Moneycontrol PRO
LAMF
LAMF

Torrent Pharmaceuticals share price falls 2.02% in Friday's trading session

At 11:11 am, Torrent Pharmaceuticals was trading at Rs 3,666.20, marking a decrease of 2.02% from its previous closing price.
August 01, 2025 / 11:18 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

Shares of Torrent Pharmaceuticals declined by 2.02% to Rs 3,666.20 as of 11.11 am in Friday's trading session. This movement reflects the investor sentiment, with the stock trading lower compared to its previous close. The stock is included as one of the stocks in the benchmark NIFTY NEXT 50 index.

Financial Performance:

The financial performance of Torrent Pharmaceuticals reveals the following trends based on consolidated figures:

Quarterly Results:

For the quarter ending June 2025, the company's revenue stood at Rs 3,178 Crore, a rise from Rs 2,859 Crore in June 2024. The net profit for the same period was Rs 548 Crore, up from Rs 457 Crore in the corresponding quarter of the previous year. The EPS increased to Rs 16.19 in June 2025 from Rs 13.51 in June 2024.

Annual Results:

The annual revenue for the year ending March 2025 was Rs 11,516.09 Crore, compared to Rs 10,727.84 Crore for the year ending March 2024. Net profit also saw an increase, reaching Rs 1,911.25 Crore in March 2025, up from Rs 1,656.38 Crore in March 2024. The EPS rose from Rs 48.94 in March 2024 to Rs 56.47 in March 2025.

A detailed overview of the financial performance is provided in the tables below:

ParticularsJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
RevenueRs 2,859.00 CroreRs 2,889.00 CroreRs 2,809.00 CroreRs 2,959.00 CroreRs 3,178.00 Crore
Net ProfitRs 457.00 CroreRs 453.00 CroreRs 503.00 CroreRs 498.00 CroreRs 548.00 Crore
EPS13.5113.3714.8814.7116.19
Particulars20212022202320242025
RevenueRs 8,004.57 CroreRs 8,508.04 CroreRs 9,620.15 CroreRs 10,727.84 CroreRs 11,516.09 Crore
Net ProfitRs 1,251.88 CroreRs 777.18 CroreRs 1,245.23 CroreRs 1,656.38 CroreRs 1,911.25 Crore
EPS73.9845.9336.7948.9456.47
BVPS344.90351.75183.13202.57224.27
ROE21.4413.0520.0924.1525.17
Debt to Equity0.830.670.850.570.40

The revenue for the year ending March 2025 increased by 7.35% compared to the year ending March 2024. Similarly, the net profit for the year ending March 2025 saw a significant increase of 15.4% compared to the year ending March 2024.

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Sales11,51610,7279,6208,5088,004
Other Income23574519656
Total Income11,53910,7859,6658,7048,061
Total Expenditure8,6148,0807,4847,2236,182
EBIT2,9252,7052,1801,4801,879
Interest252353333255352
Tax761695601448274
Net Profit1,9111,6561,2457771,251

Corporate Actions:

The company has announced several corporate actions, including dividend payouts. Recent announcements include the transcript of the conference call regarding earnings under Regulation 30 (LODR) and the audio recording of the conference call with analysts/investors on the financial results for the quarter ended June 30, 2025.

The company announced a final dividend of Rs 6 per share (120%) on May 20, 2025, with an effective date of June 20, 2025. Additionally, an interim dividend of Rs 26 per share (520%) was announced on January 14, 2025, with an effective date of January 31, 2025.

Torrent Pharmaceuticals has also a history of bonus issues. The company issued bonus shares in the ratio of 1:1 on multiple occasions, including May 25, 2022 and May 30, 2013.

The company had split its shares on Dec 15, 2005, where the face value changed from Rs 10 to Rs 5. The exsplit and record date for the same were February 20, 2006 and February 27, 2006 respectively.

Moneycontrol analysis suggests a very bullish sentiment surrounding Torrent Pharmaceuticals as of August 1, 2025.

At 11:11 am, Torrent Pharmaceuticals was trading at Rs 3,666.20, marking a decrease of 2.02% from its previous closing price.

Alpha Desk
first published: Aug 1, 2025 11:18 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347